Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2000-11-27
2002-11-26
Azpuru, Carlos (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S501000, C514S772300, C428S402000
Reexamination Certificate
active
06485737
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to biodegradable homopolymer and block copolymer compositions, in particular those containing both phosphonate and terephthalate ester linkages in the polymer backbone, which degrade in vivo into non-toxic residues. The copolymers of the invention are particularly useful as implantable medical devices and drug delivery systems.
2. Description of the Prior Art
Biocompatible polymeric materials have been used extensively in therapeutic drug delivery and medical implant device applications. Sometimes, it is also desirable for such polymers to be, not only biocompatible, but also biodegradable to obviate the need for removing the polymer once its therapeutic value has been exhausted.
Conventional methods of drug delivery, such as frequent periodic dosing, are not ideal in many cases. For example, with highly toxic drugs, frequent conventional dosing can result in high initial drug levels at the time of dosing, often at near-toxic levels, followed by low drug levels between doses that can be below the level of their therapeutic value. However, with controlled drug delivery, drug levels can be more easily maintained at therapeutic, but non-toxic, levels by controlled release in a predictable manner over a longer term.
If a biodegradable medical device is intended for use as a drug delivery or other controlled-release system, using a polymeric carrier is one effective means to deliver the therapeutic agent locally and in a controlled fashion, see Langer et al., “Chemical and Physical Structures of Polymers as Carriers for Controlled Release of Bioactive Agents”,
J. Macro. Science, Rev. Macro. Chem. Phys.,
C23:1, 61-126 (1983). As a result, less total drug is required, and toxic side effects can be minimized. Polymers have been used as carriers of therapeutic agents to effect a localized and sustained release. See Leong et al., “Polymeric Controlled Drug Delivery”,
Advanced Drug Delivery Reviews,
1:199-233 (1987) and Langer, “New Methods of Drug Delivery”,
Science,
249:1527-33 (1990); and Chien et al.,
Novel Drug Delivery Systems
(1982). Such delivery systems offer the potential of enhanced therapeutic efficacy and reduced overall toxicity.
For a non-biodegradable matrix, the steps leading to release of the therapeutic agent are water diffusion into the matrix, dissolution of the therapeutic agent, and diffusion of the therapeutic agent out through the channels of the matrix. As a consequence, the mean residence time of the therapeutic agent existing in the soluble state is longer for a non-biodegradable matrix than for a biodegradable matrix, for which passage through the channels of the matrix, while it may occur, is no longer required. Since many pharmaceuticals have short half-lives, therapeutic agents can decompose or become inactivated within the non-biodegradable matrix before they are released.
This issue is particularly significant for many bio-macromolecules and smaller polypeptides, since these molecules are generally hydrolytically unstable and have low permeability through a polymer matrix. In fact, in a non-biodegradable matrix, many bio-macromolecules aggregate and precipitate, blocking the channels necessary for diffusion out of the carrier matrix.
These problems are alleviated by using a biodegradable matrix that, in addition to some diffusion release, also allows controlled release of the therapeutic agent by degradation of the polymer matrix. Examples of classes of synthetic polymers that have been studied as possible biodegradable materials include polyesters (Pitt et al., “Biodegradable Drug Delivery Systems Based on Alipathic Polyesters: Application to Contraceptives and Narcotic Antagonists”,
Controlled Release of Bioactive Materials,
19-44 (Richard Baker ed., 1980); poly(amino acids) and pseudo-poly(amino acids) (Pulapura et al., “Trends in the Development of Bioresorbable Polymers for Medical Applications,”
J. of Biomaterials Appl.,
6:1, 216-50 (1992); polyurethanes (Bruin et al., “Biodegradable Lysine Diisocyanate-based Poly-(Glycolide-co-&egr; Caprolactone)-Urethane Network in Artificial Skin”,
Biomaterials,
11:4, 291-95 (1990); polyorthoesters (Heller et al., “Release of Norethindrone from Poly(Ortho Esters)”,
Polymer Engineering Sci.,
21:11, 727-31 (1981); and polyanhydrides (Leong et al., “Polyanhydrides for Controlled Release of Bioactive Agents”,
Biomaterials,
7:5, 364-71 (1986).
Specific examples of biodegradable materials that are used as medical implant materials are polylactide, polyglycolide, polydioxanone, poly(lactide-co-glycolide), poly(glycolide-co-polydioxanone), polyanhydrides, poly(glycolide-co-trimethylene carbonate), and poly(glycolide-co-caprolactone). Injectable polyphosphazenes have also been described as useful for forming solid biodegradable implants in situ. See, Dunn et al., in U.S. Pat. Nos. 5,340,849; 5,324,519; 5,278,202; and 5,278,201.
Polymers having phosphoester linkages, called poly(phosphates), poly(phosphonates) and poly(phosphites), are known. See Penczek et al.,
Handbook of Polymer Synthesis,
Chapter 17: “Phosphorus-Containing Polymers”, 1077-1132 (Hans R. Kricheldorf ed., 1992). The respective structures of each of these three classes of compounds, each having a different side chain connected to the phosphorus atom, is as follows:
The versatility of these polymers comes from the versatility of the phosphorus atom, which is known for a multiplicity of reactions. Its bonding can involve the 3p orbitals or various 3s-3p hybrids; spd hybrids are also possible because of the accessible d orbitals. Thus, the physico-chemical properties of the poly(phosphoesters) can be readily changed by varying either the R or R′ group. The biodegradability of the polymer is due primarily to the physiologically labile phosphoester bond in the backbone of the polymer. By manipulating the backbone or the side chain, a wide range of biodegradation rates are attainable. Kadiyala et al.,
Biomedical Applications of Synthetic Biodegradable Polymers,
Chapter 3: “Poly(phosphoesters): Synthesis, Physicochemical Characterization and Biological Response”, 33-57, 34-5 (Jeffrey O. Hollinger ed., 1995).
An additional feature of poly(phosphoesters) is the availability of functional side groups. Because phosphorus can be pentavalent, drug molecules or other biologically active substances can be chemically linked to the polymer. For example, drugs with —O -carboxy groups may be coupled to the phosphorus via an ester bond, which is hydrolyzable. The P—O—C group in the backbone also lowers the glass transition temperature of the polymer and, importantly, confers solubility in common organic solvents, which is desirable for easy characterization and processing. Kadiyala et al. at page 35.
Specifically, EP 386 757 discloses the use of poly(phosphate) esters as prostheses and therapeutic agent delivery vehicles, recognizing that the polymers are biodegradable because of the hydrolyzable phosphoester bond in the backbone. With phosphorous in the trivalent state, the polymers can be polyphosphates or polyphosphonates having the general formula:
where R and R′ are organic or organometallic moieties, and n is from about 10 to about 10
5
.
Similarly, EP 057 116 discloses biocompatible polyphosphate esters with difunctional oligomers joined by phosphate bridging structures of general formula I:
where n≧2; OL is an oligomer, preferably chosen from the group compring polyethylene terephthalate and polybutylene terephthalate; Y and Z are the two functional groups of the oligomer, such as OH; and R can be a substituted or unsubstituted alkyl, aryl or aralkyl group. These compounds are described as allowing for easy adjustment of the biodegradability.
Kadiyala et al. specifically discloses reacting bis(2-hydroxyethyl) terephthalate with dimethyl phosphite to form the following biodegradable poly-(phosphite):
The corresponding terephthalate poly(phosphate) materials have been described as biodegradable materials in copending U.S. patent application Ser.
Dang Wenbin
English James P.
Leong Kam W.
Mao Hai-quan
Nowotnik David P.
Azpuru Carlos
Foley & Hoag LLP
Guilford Pharmaceuticals Inc.
LandOfFree
Biodegradable terephthalate polyester-poly (phosphonate)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biodegradable terephthalate polyester-poly (phosphonate)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biodegradable terephthalate polyester-poly (phosphonate)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2939802